tiprankstipranks
Lifecore Biomedical (LFCR)
NASDAQ:LFCR
US Market

Lifecore Biomedical (LFCR) Income Statement

Compare
134 Followers

Lifecore Biomedical Income Statement

Last quarter (Q2 2025), Lifecore Biomedical's total revenue was $32.56M, an increase of 8.01% from the same quarter last year. In Q2, Lifecore Biomedical's net income was $-6.57M. See Lifecore Biomedical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
$ 128.26M$ 103.27M$ 185.79M$ 544.16M$ 590.37M
Gross Profit
$ 41.85M$ 27.29M$ 50.55M$ 81.47M$ 74.99M
Operating Expenses
$ 49.04M$ 51.26M$ 50.47M$ 75.59M$ 83.29M
Depreciation and Amortization
$ 8.86M$ 10.30M$ 7.10M$ 8.61M$ 18.30M
EBITDA
$ 35.60M$ -35.98M$ 1.96M$ 13.00M$ -7.16M
Operating Income
$ 9.33M$ -26.08M$ 3.46M$ -6.86M$ -8.30M
Other Income/Expenses
$ 183.00K$ -42.13M$ -8.90M$ -20.96M$ -4.77M
Pretax Income
$ 9.51M$ -68.70M$ -51.92M$ -40.47M$ -51.31M
Net Income
$ 12.01M$ -102.19M$ -46.08M$ -32.66M$ -38.19M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.39$ -3.41$ -1.56$ -1.12$ -1.31
Diluted EPS
$ 0.33$ -3.41$ -1.56$ -1.12$ -1.31
Weighted Average Shares Outstanding
30.47M 29.96M 29.47M 29.29M 29.16M
Weighted Average Shares Outstanding (Diluted)
36.66M 29.96M 29.47M 29.29M 29.16M
Currency in USD

Lifecore Biomedical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis